Concepedia

Kol A. Zarember

KA

38

Publications

5.6K

Citations

32

H-Index

1993

Active since

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

National Institutes of Health

Science Applications International Corporation (United States)

Harvard University

Frederick National Laboratory for Cancer Research

Kol A. Zarember is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, immunology, and inflammation.

ORCID

Top concepts

Publications per year

1993–2024

38

Publications

38

Tissue Expression of Human Toll-Like Receptors and Differential Regulation of Toll-Like Receptor mRNAs in Leukocytes in Response to Microbes, Their Products, and Cytokines

Kol A. Zarember, Paul J. Godowski · The Journal of Immunology · 2002 · 1.2K citations

, , +17

Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease

Douglas B. Kuhns, W. Gregory Alvord, Theo Heller et al. · New England Journal of Medicine · 2010 · 551 citations · Full text

Selective Impairment of TLR-Mediated Innate Immunity in Human Newborns: Neonatal Blood Plasma Reduces Monocyte TNF-α Induction by Bacterial Lipopeptides, Lipopolysaccharide, and Imiquimod, but Preserves the Response to R-848

Ofer Levy, Kol A. Zarember, René M. Roy et al. · The Journal of Immunology · 2004 · 374 citations · Full text

, , +26

An immune-based biomarker signature is associated with mortality in COVID-19 patients

Michael S. Abers, Ottavia M. Delmonte, Emily Ricotta et al. · JCI Insight · 2020 · 357 citations · Full text

Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency

Suk See De Ravin, Xiaolin Wu, Susan Moir et al. · Science Translational Medicine · 2016 · 284 citations · Full text

Rows per page

1–5 of 38